3Andekson T, Hassan - Alin M, Hasselgren G, et al. Pharmaeokinetic studies with esomeprazole, the (s) isomer of omeprazole. Clin Pharmacokinet, 2001, 40 (6): 411
二级参考文献7
1Freitas DS, Sofia C, Pontes JM, et al. Octreotide in acute bleeding esophageal varices: a prospective randomized study.Hepatogastroenterology, 2000, 47:1310-1314.
2Feu ET, Del Arbol, Banares R, et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology, 1996,111 : 1291-1299.
3Comar KM, Sanyal AJ. Portal hypertension bleeding.Gastroenterol Clin North Am, 2003, 32: 1079-1105.
4Zaman A. Current management of esophageal varices. Curr Treat Options Gastroenterol, 2003, 6: 499-457.
5Yillanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology, 2001, 121:110-117.
6Bildozola M, Kravetz D, Argonz T, et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial. Scand J Gastroenterol, 2000, 35 : 419-425.
7. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects[J] 2000,European Journal of Clinical Pharmacology(9-10):665～670
7Henrion J,Schapira M,Ghilain J M. Upper gastrointestinal bleeding:what has changed during the last 20 years[J].Gastroenterologie Clinique et Biologique,2008,(10):839-847.
8Higgins J P T,Green S. Cochrance Handbook for Systematic Reviews of Interventions 4.2.6,2006[M].The Cochrane Collaboration,.
